Analgesics

Despite a decline in the number of COVID-19 cases, demand for analgesics continued to grow in 2023. This was partly due to the revival of pre-pandemic behavioural patterns, including the cessation of mask wearing and social distancing, which meant…

Analgesics remains the largest category in consumer health in Nigeria. Sales continued to rise in 2023, supported by strong brand positioning and consumer awareness. Other factors driving growth included affordability, widespread availability and a…

Consumers are increasingly embracing self-medication, especially for minor illnesses, and this contributed to modest growth in 2023, as well as continuing population growth. Analgesics have achieved a substantial penetration rate in Cameroon,…

Analgesics experienced a rise in unit prices due to inflationary pressure, which pushed up the price of imported medications and locally-produced options. Current value growth accelerated in 2023 as a result of this trend. Brand loyalty remains…

Analgesics is set to maintain steady current value growth in Brazil in 2023, and will remain the largest category within OTC, with a 40% share of value sales. The consumption of analgesics is mainly related to general pain, fever, and the relief of…

The reopened border between mainland China and Hong Kong in early 2023 had significant implications for the demand of analgesic remedies within the city, which rose considerably. This growth can be attributed to a shortage of analgesic remedies…

Towards the end of the review period, demand for analgesics was supported by the widening of the consumer base for these products as the advantages of using analgesics to manage headaches and other moderate types of pain became better known among the…

Analgesics is failing to record a strong performance in Lithuania in 2023; following the pandemic years, sales are stagnating, reflecting the saturated market and consumer base. In addition, a growing scepticism and concern about the overreliance on…

Due to the high rates of vaccination amongst Singaporeans, systemic analgesics were purchased in high quantities in 2022 to fulfil the demand to self-medicate amidst post-vaccination symptoms and common cold symptoms from later variants of the…

In 2023, the COVID-19 pandemic has lost some of its disruptive potency; however, analgesic sales in Azerbaijan are ticking upwards in value terms (with the exception of adult aspirin). Value sales are being pushed by Azerbaijan's reliance on imports,…

Since 2020, a factor supporting the growth of analgesics was the increased tendency of doctors to prescribe acetaminophen, among other common types of analgesics, as a way of managing the symptoms of patients with COVID-19, including muscle and joint…

There are interesting developments in terms of diverging performances within adult systemic analgesics. In 2023, acetaminophen is set to drive current value growth, and significantly outpace the overall performance of adult analgesics. Growth in…

Analgesics in Morocco has continued to develop positively in 2023, with total current value sales set to grow at a faster rate than in 2022 and most categories expected to post improved results in volume terms. Together with population growth and…

Pharmacies continue to have significant influence over the value sales of analgesics in Ecuador. For instance, in lower income neighbourhoods, pharmacies are generally stocked with generics, whereas in wealthier neighbourhoods, mainly branded…

Systematic analgesics is expected to register positive retail value (constant 2023 prices) growth over 2023, after a spike in 2022 driven by very strong demand for paediatric analgesics, as well as fast demand for adult pain relief, as respiratory…

Analgesics continued to see solid growth in current value terms in 2023, following the easing of most COVID-19-related restrictions in September 2022. With measures such as lockdowns, mandatory mask-wearing and social distancing no longer in place,…

Sales of analgesics in Japan have seen solid growth in current value terms in 2023 backed by increased opportunities for consumers to go out, the recovery in the number of inbound tourists, and a move away from the practice of wearing face masks on a…

In the context of transforming the health system in Indonesia, one of the agendas currently being pursued by the Ministry of Health is to increase pharmaceutical resilience by increasing domestic production of the top 10 value medicines, which…

Demand for both adult and paediatric analgesics continued to grow in retail volume terms in 2023. Such products are widely used in Poland, particularly in the case of pain which is fleeting or immediate. With the rapid pace of modern life, consumers…

While analgesics performed well during the pandemic, they has returned to more moderate growth now that the threat has subsided. In 2023, analgesics is expected to register moderate current value growth, though constant value sales are expected to…